Valeant Seeks Lender List of Demands for Waiving Default

Valeant Works With Lenders to Find Ways to Waive Default

Valeant Pharmaceuticals International Inc.’s bankers have begun approaching some of its lenders to gauge what they’ll want in return for waiving a default caused by its delayed earnings filing, according to people with knowledge of the matter.

To continue reading this article you must be a Bloomberg Professional Service Subscriber.